Business Wire12.13.18
Bovie Medical Corporation, a maker of medical devices and supplies and the developer of J-Plasma, a patented surgical product marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market, announced a corporate rebranding and company name change to Apyx Medical Corporation effective January 1, 2019. The Company also announced plans to move its stock exchange listing to the NASDAQ Global Select Market from the New York Stock Exchange. The company expects that its common stock will commence trading on the NASDAQ Global Select Market on January 2, 2019, under a new ticker symbol—“APYX”.
“We are pleased to join the world’s most innovative and growth-oriented companies listed on NASDAQ and are excited to partner with NASDAQ to leverage trading liquidity, enhanced visibility for issuers, leading technology and cost efficiencies,” said Charlie Goodwin, president and CEO. “We also announced a corporate rebranding and Company name change to Apyx Medical Corporation which is the final milestone resulting from the previously announced divestiture and sale of the Core business segment and Bovie brand to Symmetry Surgical Inc.”
Goodwin continued: “The new name and brand emphasizes the company’s goal to be the most innovative, customer and solution focused company in the cosmetic surgery market and the broader medical technology sector. Apyx Medical Corporation endeavors to reshape the cosmetic surgery market by providing unique and creative solutions for the ever-changing needs of our physician customers and their patients.”
The company will ring the NASDAQ Stock Market opening bell on January 3, 2019, in Times Square, New York, N.Y. President and CEO Charlie Goodwin and members of the Company’s management team and Board of Directors will participate in the opening bell ringing ceremony from 9:00 am to 9:30 am ET.
“We are pleased to join the world’s most innovative and growth-oriented companies listed on NASDAQ and are excited to partner with NASDAQ to leverage trading liquidity, enhanced visibility for issuers, leading technology and cost efficiencies,” said Charlie Goodwin, president and CEO. “We also announced a corporate rebranding and Company name change to Apyx Medical Corporation which is the final milestone resulting from the previously announced divestiture and sale of the Core business segment and Bovie brand to Symmetry Surgical Inc.”
Goodwin continued: “The new name and brand emphasizes the company’s goal to be the most innovative, customer and solution focused company in the cosmetic surgery market and the broader medical technology sector. Apyx Medical Corporation endeavors to reshape the cosmetic surgery market by providing unique and creative solutions for the ever-changing needs of our physician customers and their patients.”
The company will ring the NASDAQ Stock Market opening bell on January 3, 2019, in Times Square, New York, N.Y. President and CEO Charlie Goodwin and members of the Company’s management team and Board of Directors will participate in the opening bell ringing ceremony from 9:00 am to 9:30 am ET.